Global Retirement Partners’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.4K | Buy |
+146
| New | +$18.4K | ﹤0.01% | 2335 |
|
|
2024
Q4 | $18K | Sell |
132
-7
| -5% | -$956 | ﹤0.01% | 2143 |
|
|
2024
Q3 | $16K | Sell |
139
-13
| -9% | -$1.5K | ﹤0.01% | 2100 |
|
|
2024
Q2 | $20.9K | Sell |
152
-40
| -21% | -$5.51K | ﹤0.01% | 1960 |
|
|
2024
Q1 | $26.5K | Buy |
192
+8
| +4% | +$1.1K | ﹤0.01% | 1689 |
|
|
2023
Q4 | $24.4K | Sell |
184
-87
| -32% | -$11.5K | ﹤0.01% | 1663 |
|
|
2023
Q3 | $30K | Buy |
271
+13
| +5% | +$1.44K | ﹤0.01% | 1494 |
|
|
2023
Q2 | $24.3K | Buy |
258
+147
| +132% | +$13.9K | ﹤0.01% | 1591 |
|
|
2023
Q1 | $10.9K | Buy |
111
+5
| +5% | +$493 | ﹤0.01% | 1888 |
|
|
2022
Q4 | $12.7K | Sell |
106
-5
| -5% | -$597 | ﹤0.01% | 1687 |
|
|
2022
Q3 | $13K | Buy |
111
+103
| +1,288% | +$12.1K | ﹤0.01% | 1580 |
|
|
2022
Q2 | $1K | Hold |
8
| – | – | ﹤0.01% | 2486 |
|
|
2022
Q1 | $1K | Buy |
+8
| New | +$1K | ﹤0.01% | 2453 |
|
|
2021
Q1 | – | Sell |
-19
| Closed | -$2K | – | 1846 |
|
|
2020
Q4 | $2K | Buy |
+19
| New | +$2K | ﹤0.01% | 1611 |
|